Mallinckrodt Public Limited Company - 6 Year Stock Split History | MNK

Stock split history for Mallinckrodt Public Limited Company since 2013. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Mallinckrodt Public Limited Company Annual Stock Splits
Mallinckrodt Public Limited Company Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.719B $3.222B
Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company's Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt Plc. is based in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $54.040B 9.28
Teva Pharmaceutical Industries (TEVA) Israel $19.138B 5.86
Mylan (MYL) United Kingdom $15.258B 6.28
Bausch Health Cos (BHC) Canada $8.076B 5.85
Dr Reddy's Laboratories (RDY) India $6.150B 24.53
Supernus Pharmaceuticals (SUPN) United States $1.988B 18.84
Amphastar Pharmaceuticals (AMPH) United States $1.011B 109.70
Homology Medicines (FIXX) United States $0.857B 0.00
Assembly Biosciences (ASMB) United States $0.535B 0.00
CymaBay Therapeutics (CBAY) United States $0.531B 0.00
Akorn (AKRX) United States $0.451B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.415B 0.00
Voyager Therapeutics (VYGR) United States $0.269B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.247B 0.00
Sol-Gel Technologies (SLGL) Israel $0.110B 0.00
Teligent (TLGT) United States $0.094B 0.00
Acasti Pharma (ACST) Canada $0.087B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.069B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.056B 0.00
Evoke Pharma (EVOK) United States $0.049B 0.00
Agile Therapeutics (AGRX) United States $0.031B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.006B 0.00